title: Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
abstract: Multiple sclerosis (MS) is a chronic and devastating autoimmune demyelinating disease of the central nervous system. With the increased understanding of the pathophysiology of this disease in the past two decades, many disease-modifying therapies that primarily target adaptive immunity have been shown to prevent exacerbations and new lesions in patients with relapsing-remitting MS. However, these therapies only have limited efficacy on the progression of disability. Increasing evidence has pointed to innate immunity, axonal damage and neuronal loss as important contributors to disease progression. Remyelination of denuded axons is considered an effective way to protect neurons from damage and to restore neuronal function. The identification of several key molecules and pathways controlling the differentiation of oligodendrocyte progenitor cells and myelination has yielded clues for the development of drug candidates that directly target remyelination and neuroprotection. The long-term efficacy of this strategy remains to be evaluated in clinical trials. Here, we provide an overview of current and emerging therapeutic concepts, with a focus on the opportunities and challenges for the remyelination approach to the treatment of MS.
authors.affiliation: Neuroimmunology Discovery Performance Unit, GlaxoSmithKline Research and Development Center, Shanghai, China.
authors.forename: Yueting
authors.initials: Y
authors.lastname: Zhang
authors.forename: Taylor B
authors.initials: TB
authors.lastname: Guo
authors.forename: Hongtao
authors.initials: H
authors.lastname: Lu
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D006233:Persons with Disabilities; D004195:Disease Models, Animal; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications / Q000276:immunology / Q000378:metabolism* / Q000628:therapy*; D009186:Myelin Sheath / Q000502:physiology*; D009416:Nerve Regeneration / Q000187:drug effects / Q000502:physiology*; D009836:Oligodendroglia / Q000187:drug effects / Q000502:physiology
chemical_list: D007155:Immunologic Factors
references.citation: Ann Neurol. 2001 Sep;50(3):389-400
references.pmid: 11558796
references.citation: J Neuropathol Exp Neurol. 2003 Jul;62(7):723-32
references.pmid: 12901699
references.citation: Glia. 2011 Mar;59(3):363-78
references.pmid: 21264945
references.citation: Neuron. 1998 Jul;21(1):63-75
references.pmid: 9697852
references.citation: Nat Med. 2002 Oct;8(10):1115-21
references.pmid: 12357247
references.citation: Nature. 2008 Feb 28;451(7182):1076-81
references.pmid: 18278032
references.citation: Exp Neurol. 2008 Aug;212(2):458-67
references.pmid: 18572165
references.citation: Brain. 2004 Sep;127(Pt 9):1928-41
references.pmid: 15289265
references.citation: Neuroimage. 2006 Jan 15;29(2):637-42
references.pmid: 16126413
references.citation: Neurosci Res. 1993 Sep;17(4):265-90
references.pmid: 8264989
references.citation: J Neurosci Res. 1989 Apr;22(4):369-83
references.pmid: 2668542
references.citation: Ann Neurol. 2011 Apr;69(4):673-80
references.pmid: 21337603
references.citation: Brain. 2002 Sep;125(Pt 9):1972-9
references.pmid: 12183343
references.citation: Nat Neurosci. 2011 Jun 26;14(8):1009-16
references.pmid: 21706018
references.citation: J Neurochem. 2010 Oct;115(1):11-22
references.pmid: 20193041
references.citation: J Biol Chem. 2007 Jun 1;282(22):16700-11
references.pmid: 17420257
references.citation: Nat Genet. 2009 Jul;41(7):854-8
references.pmid: 19503091
references.citation: Cell. 2002 Apr 5;109(1):75-86
references.pmid: 11955448
references.citation: Ann Neurol. 2009 Mar;65(3):304-15
references.pmid: 19334062
references.citation: J Neurocytol. 1995 Oct;24(10):775-81
references.pmid: 8586997
references.citation: Neuroreport. 2004 Oct 5;15(14):2167-72
references.pmid: 15371726
references.citation: Genes Dev. 2009 Jul 1;23(13):1571-85
references.pmid: 19515974
references.citation: Brain. 2008 Jul;131(Pt 7):1749-58
references.pmid: 18515322
references.citation: J Neurosci. 2009 Jul 22;29(29):9174-85
references.pmid: 19625508
references.citation: Stem Cells. 2007 Dec;25(12):3204-14
references.pmid: 17872503
references.citation: Brain Pathol. 2001 Jan;11(1):107-16
references.pmid: 11145196
references.citation: Nat Neurosci. 2009 Jul;12(7):829-38
references.pmid: 19503085
references.citation: J Neurosci. 1998 Jan 15;18(2):601-9
references.pmid: 9425002
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10851-6
references.pmid: 11526205
references.citation: Nat Neurosci. 2004 Mar;7(3):221-8
references.pmid: 14966521
references.citation: Magn Reson Med. 1994 Jun;31(6):673-7
references.pmid: 8057820
references.citation: PLoS One. 2012;7(7):e40457
references.pmid: 22792334
references.citation: Exp Neurol. 2005 Aug;194(2):363-75
references.pmid: 16022864
references.citation: PLoS One. 2012;7(11):e48797
references.pmid: 23144976
references.citation: J Neurosci. 2007 Jan 3;27(1):220-5
references.pmid: 17202489
references.citation: Ann Neurol. 2012 Aug;72(2):224-33
references.pmid: 22807310
references.citation: Glia. 2012 Oct;60(10):1590-604
references.pmid: 22777942
references.citation: Cell. 2003 Oct 17;115(2):163-75
references.pmid: 14567914
references.citation: Annu Rev Immunol. 2012;30:429-57
references.pmid: 22224772
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9304-9
references.pmid: 16754874
references.citation: Development. 2001 Jul;128(14):2723-33
references.pmid: 11526078
references.citation: J Neurotrauma. 2003 Sep;20(9):871-82
references.pmid: 14577865
references.citation: Development. 2006 Sep;133(17):3389-98
references.pmid: 16908628
references.citation: Brain. 2011 Sep;134(Pt 9):2755-71
references.pmid: 21840891
references.citation: J Neurosci. 2012 May 9;32(19):6651-64
references.pmid: 22573687
references.citation: J Neurol. 2008 Mar;255 Suppl 1:3-11
references.pmid: 18317671
references.citation: J Neurosci. 2012 Sep 5;32(36):12528-42
references.pmid: 22956843
references.citation: J Neurosci Res. 2010 Sep;88(12):2546-57
references.pmid: 20544820
references.citation: N Engl J Med. 2002 Jan 17;346(3):165-73
references.pmid: 11796850
references.citation: J Biol Chem. 2011 Mar 25;286(12):10593-604
references.pmid: 21209081
references.citation: Development. 2004 Sep;131(17):4131-42
references.pmid: 15280210
references.citation: Nat Med. 2007 Oct;13(10):1228-33
references.pmid: 17906634
references.citation: Ann Neurol. 2000 Jun;47(6):707-17
references.pmid: 10852536
references.citation: Brain. 2005 Nov;128(Pt 11):2705-12
references.pmid: 16230320
references.citation: J Cell Biol. 2008 May 19;181(4):579-86
references.pmid: 18490510
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14883-8
references.pmid: 16195382
references.citation: J Neurosci. 2011 Mar 23;31(12):4504-10
references.pmid: 21430151
references.citation: Nat Neurosci. 2009 Nov;12(11):1398-406
references.pmid: 19838178
references.citation: Neuron. 1996 Oct;17(4):595-606
references.pmid: 8893018
references.citation: Neuron. 2000 Feb;25(2):331-43
references.pmid: 10719889
references.citation: J Cell Biol. 1988 May;106(5):1735-46
references.pmid: 2453520
references.citation: N Engl J Med. 2011 Dec 8;365(23):2188-97
references.pmid: 22150037
references.citation: Expert Opin Ther Pat. 2010 Dec;20(12):1767-73
references.pmid: 20954805
references.citation: J Neurosci. 2005 Feb 9;25(6):1354-65
references.pmid: 15703389
references.citation: Exp Neurol. 2012 May;235(1):357-67
references.pmid: 22421533
references.citation: Nat Neurosci. 2011 Jan;14(1):45-53
references.pmid: 21131950
references.citation: Neuron. 2008 Nov 26;60(4):555-69
references.pmid: 19038214
references.citation: Development. 2008 Feb;135(4):637-46
references.pmid: 18184726
references.citation: Neuron. 2007 Jul 19;55(2):217-30
references.pmid: 17640524
references.citation: Genes Dev. 2010 Feb 1;24(3):301-11
references.pmid: 20080941
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19162-7
references.pmid: 19855010
references.citation: Cell. 2009 Jul 10;138(1):172-85
references.pmid: 19596243
references.citation: J Neurosci. 2008 Dec 24;28(52):14189-201
references.pmid: 19109501
references.citation: Nat Neurosci. 2006 Dec;9(12):1506-11
references.pmid: 17099706
references.citation: PLoS One. 2008;3(10):e3579
references.pmid: 18974869
references.citation: Glia. 2012 Jul;60(7):1037-52
references.pmid: 22461009
references.citation: Neuropathol Appl Neurobiol. 2007 Feb;33(1):99-107
references.pmid: 17239012
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7585-90
references.pmid: 10840047
references.citation: Nat Neurosci. 2007 Jan;10(1):19-26
references.pmid: 17189949
references.citation: Nature. 1988 Jun 9;333(6173):562-5
references.pmid: 3287177
references.citation: Nat Neurosci. 2005 Jun;8(6):745-51
references.pmid: 15895088
references.citation: Mol Cell Neurosci. 2007 Oct;36(2):260-9
references.pmid: 17719796
references.citation: Development. 2000 Jul;127(14):2989-98
references.pmid: 10862737
references.citation: Anat Embryol (Berl). 1991;184(4):395-401
references.pmid: 1952111
references.citation: Eur J Neurosci. 1995 Mar 1;7(3):480-91
references.pmid: 7773445